Back

Investor Relations  Financial Information

Segment and Regional Information

Consolidated Financial Results by Business Segment

Net Sales

(Unit: Millions of yen)
 Medical-RelatedPharmaceutical-RelatedPharmaPackagingOtherTotal
'18/3 300,117 60,080 35,170 29 395,397
'19/3 327,359 63,482 35,526 31 426,399
'20/3 335,767 70,357 36,217 174 442,516
'21/3 347,648 68,564 38,655 691 455,559

* Reporting Segment was changed as a result of the corporate reorganization.
The segment information is presented as if the reorganization had been conducted at the beginning of the fiscal year 2018.


Operating Income

(Unit: Millions of yen)
 Medical-RelatedPharmaceutical-RelatedPharmaPackagingOtherAdjustmentTotal
'18/3 36,522 11,428 367 75 -21,306 27,088
'19/3 36,722 10,662 778 146 -24,482 23,827
'20/3 36,249 13,196 675 176 -23,877 26,420
'21/3 39,415 10,072 1,992 376 -24,228 27,627

Net Sales by Region

(Unit: Millions of yen)
 JapanAmericaEuropeAsiaTotal
Net salesProportion Net salesProportion Net salesProportion Net salesProportion Net sales
'18/3 241,750 61.2% 56,704 14.3% 46,389 11.7% 50,553 12.8% 395,397
'19/3 260,967 61.2% 59,836 14.0% 51,042 12.0% 54,552 12.8% 426,399
'20/3 267,708 60.5% 64,153 14.5% 50,801 11.5% 59,853 13.5% 442,516
'21/3 270,543 59.4% 71,572 15.7% 52,167 11.5% 61,275 13.5% 455,559

Proportion of Net Sales by Region (2021/3)

Page top